The ASX shrugged off the Fed’s first rate hike since 2023, as banks rallied, goldies slipped and Trump demanded cheaper money ...

Latrobe scores US$15m support for US magnesium push as Arrow targets Pilbara iron ore prospective ground next to Rio Tinto.

Dermatology focused Botanix Pharmaceuticals has embarked on a health kick in a bid to improve margins, cut costs and boost sales.

Australians must prove that they are over 18 to access certain features under Apple’s age verification push designed to ...

De Grey Mining is one of the WA gold industry's legendary stories. This small gold developer has some of its key names ...

Uranium junior Core Energy Minerals has expanded its presence in the world-class Erongo province as yellowcake primes for a ...

The ASX eked out a 0.28% gain as surging oil fired up energy stocks, while investors braced for the Fed’s first rate hike ...

TG Metals (ASX:TG6) is mobilising an aircore rig to test extensions of laterite gold mineralisation at its Van Uden project ...

If Nevada was a separate country it would be in the top three global gold producers but, surprisingly, the US state is still ...

Javelin soars on WA gold tie-up with First Au as White Cliff gains after Hancock Prospecting invests $8.7m for a 13.5% stake.

Following an upbeat healthcare earnings reporting season, RBC Capital Markets has upped its recommendation on a swathe of biotech stocks.

ASX healthcare stocks are turning to licensing and partnering deals to fund drug development, with Dimerix and Neuren showing ...